BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38601149)

  • 21. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
    Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
    Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC deaminases-mutases with defensive roles for immunity.
    Prochnow C; Bransteitter R; Chen XS
    Sci China C Life Sci; 2009 Oct; 52(10):893-902. PubMed ID: 19911124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
    Shilova ON; Tsyba DL; Shilov ES
    Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC: From mutator to editor.
    Yang B; Li X; Lei L; Chen J
    J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative and Quantitative Analysis of DNA Cytidine Deaminase Activity.
    DeWeerd R; Green AM
    Methods Mol Biol; 2022; 2444():161-169. PubMed ID: 35290637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systems biology analysis of protein-protein interactions in the APOBEC family.
    Wang Y; Chen G; Yang Y; Hu Z; Chen X
    Life Sci; 2008 Oct; 83(15-16):521-30. PubMed ID: 18793652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-redundancy of cytidine deaminases in class switch recombination.
    Fugmann SD; Rush JS; Schatz DG
    Eur J Immunol; 2004 Mar; 34(3):844-849. PubMed ID: 14991614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOBECs orchestrate genomic and epigenomic editing across health and disease.
    Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
    Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
    Huthoff H; Malim MH
    Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.
    Muramatsu M; Sankaranand VS; Anant S; Sugai M; Kinoshita K; Davidson NO; Honjo T
    J Biol Chem; 1999 Jun; 274(26):18470-6. PubMed ID: 10373455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-throughput assay for DNA deaminases.
    Wang M; Rada C; Neuberger MS
    Methods Mol Biol; 2011; 718():171-84. PubMed ID: 21370049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.